한빛사71건

• • 배성호(Brigham and Women’s Hospital and Harvard Medical School, 성균관대학교)

  • 고화연(성균관대학교)

  • 신주영(성균관대학교)

  Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazoli

  • Gut Sep 06 2024, gutjnl-2024-332687 | https://doi.org/10.1136/gutjnl-2024-332687

  • 2024.09
  • 의약학

• • 홍빈(성균관대학교)

  • 신주영(성균관대학교)

  Sodium-Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia : A Population-Based Cohort Study

  • Ann. Intern. Med. Aug 27 2024, | https://doi.org/10.7326/M23-3220

  • 2024.08
  • 의약학

• • 장호충(한국과학기술연구원 (KIST))

  • 심만규(한국과학기술연구원 (KIST))

  • 양유수(한국과학기술연구원)

  Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs

  • Theranostics Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269

  • 2024.08
  • 바이오·의료융합

• • 유미경(Alnylam Pharmaceuticals)

  Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates

  • Nucleic Acids Res. May 14 2024, gkae350 | https://doi.org/10.1093/nar/gkae350

  • 2024.05
  • 의약학

• • 이동택(고려대학교, 현 Harvard Medical School)

  • 정효기(고려대학교)

  • 박동성(고려대학교, 경희대학교 의과대학)

  • 황교선(경희대학교 의과대학)

  • 이정훈(광운대학교)

  • 윤대성(고려대학교, Astrion Inc)

  Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2

  • Nat. Commun. 07 March 2024 | https://doi.org/10.1038/s41467-024-46296-7

  • 2024.03
  • 바이오·의료융합

• • 김진성(이화여자대학교, 고려대학교)

  • 심만규(한국과학기술연구원 (KIST))

  • 김광명(이화여자대학교 약학대학)

  Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy

  • J. Nanobiotechnol. Mar 13 2024, 22 (1) 109 | https://doi.org/10.1186/s12951-024-02314-w

  • 2024.03
  • 바이오·의료융합

• • 배도현(성균관대학교, 기초과학연구원)

    Interview

  • 배하연(성균관대학교)

  • 함정엽(한국과학기술연구원(KIST))

  • 김진철(한국과학기술연구원(KIST))

    Interview

  • 김용호(성균관대학교, 기초과학연구원)

  Peptide-Drug Conjugate with Statistically Designed Transcellular Peptide for Psoriasis-Like Inflammation

  • Adv. Healthc. Mater. Feb 29 2024, | https://doi.org/10.1002/adhm.202303480

  • 2024.02

• • 박재현(Yokohama City University)

  • 박삼용(Yokohama City University)

  Structural basis of hepatitis B virus receptor binding

  • Nat. Struct. Mol. Biol. Jan 17 2024, | https://doi.org/10.1038/s41594-023-01191-5

  • 2024.01
  • 생명과학

• • 고화연(성균관대학교)

  • 배성호(성균관대학교)

  • 신주영(성균관대학교)

  Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes.

  • JAMA Netw. Open Sep 05 2023, 6 (9) | https://doi.org/10.1001/jamanetworkopen.2023.35797

  • 2023.09
  • 의약학

• • 양주원(경희대학교)

  • 배현수(경희대학교)

  Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment.

  • Exp. Mol. Med. Sep 01 2023, | https://doi.org/10.1038/s12276-023-01080-3

  • 2023.09
  • 생명과학

• • Batakrishna Jana(UNIST)

  • 진성언(UNIST, 현 한국과학기술연구원(KIST))

  • 곽상규(고려대학교)

  • 유자형(UNIST)

  Intra-Lysosomal Peptide Assembly for the High Selectivity Index against Cancer

  • J. Am. Chem. Soc. 2023 Jul 31 | https://doi.org/10.1021/jacs.3c04467

  • 2023.07
  • 바이오·의료융합

• • 송수경(이화여자대학교 약학대학)

  • 심만규(한국과학기술연구원 (KIST))

  • 김광명(이화여자대학교 약학대학)

  All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy

  • Bioact. Mater. Available online 10 June 2023 | https://doi.org/10.1016/j.bioactmat.2023.05.016

  • 2023.06
  • 바이오·의료융합

• • Sri Murugan Poongkavithai Vadevoo(경북대학교 의과대학)

  • 이병헌(경북대학교 의과대학)

  Peptides as multifunctional players in cancer therapy

  • Exp. Mol. Med. 2023 Jun 1 | https://doi.org/10.1038/s12276-023-01016-x

  • 2023.06
  • 의약학

• • 문찬희(강원대학교 의과대학)

  • 이아준(강원대학교 의과대학)

  • 하권수(강원대학교 의과대학)

  Therapeutic effect of ultra-long-lasting human C-peptide delivery against hyperglycemia-induced neovascularization in diabetic retinopathy

  • Theranostics 2023 Apr 17;13(8):2424-2438 | doi: 10.7150/thno.81714

  • 2023.04
  • 의약학

• • 정기백(한국생명공학연구원)

  • 류민주(한국생명공학연구원)

  • 김진식(한국생명공학연구원)

  • 이미경(한국생명공학연구원)

  • 지승욱(한국생명공학연구원)

  Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanopore

  • Nat. Commun. 2023 Apr 4;14(1):146 | https://doi.org/10.1038/s41467-023-37098-4

  • 2023.04
  • 생명과학

• • 최세종(서울대학교)

  • 이예은(가톨릭대학교 의과대학)

  • 구희범(가톨릭대학교 의과대학)

  • 이연(서울대학교)

  Self-cleaving protein linkers with modulated pH-responsiveness: A new platform for selective control of protein drug function

  • Chem. Eng. J. Volume 457, 1 Feb 2023, 141229 | https://doi.org/10.1016/j.cej.2022.141229

  • 2023.02
  • 바이오·의료융합

• • 정석환(University of Washington)

  Iron Oxide Nanoparticles Decorated with Functional Peptides for a Targeted siRNA Delivery to Glioma Cells

  • ACS Appl. Mater. Interfaces 2023 Jan 11;15(1):106-119 | https://doi.org/10.1021/acsami.2c17802

  • 2023.01

• • 양혜진(경희대학교)

  • 박선영(경희대학교)

    Interview

  • 김경화(동아대학교 건강과학대학 건강관리학과)

  • 배현수(경희대학교)

  Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer‘s disease

  • Theranostics 2022 Nov 7; 12(18):7668-7680. | doi:10.7150/thno.75965

  • 2022.11
  • 의약학

• • 문석준(한양대학교)

  • 조은이(한양대학교)

  • 양철수(한양대학교)

  Pathogen-derived peptides in drug targeting and its therapeutic approach

  • J. Control. Release Volume 350, October 2022, Pages 716-733 | https://doi.org/10.1016/j.jconrel.2022.08.041

  • 2022.10
  • 생명과학

• • 강병훈(한국생명공학연구원)

  • 김명희(한국생명공학연구원)

  • 임은경(한국생명공학연구원)

  FRET-based hACE2 receptor mimic peptide conjugated nanoprobe for simple detection of SARS-CoV-2

  • Chem. Eng. J. Volume 442, Part 1, 15 August 2022, 136143 | https://doi.org/10.1016/j.cej.2022.136143

  • 2022.08
  • 바이오·의료융합